MedPath

Ciprofloxacin Hydrochloride

CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC SOLUTION0.3% as baseSterile

Approved
Approval ID

2ef01a91-e73e-46d6-a6f9-d7d6dae91ea2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 23, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ciprofloxacin hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-259
Application NumberNDA019992
Product Classification
M
Marketing Category
C73594
G
Generic Name
ciprofloxacin hydrochloride
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 29, 2008
FDA Product Classification

INGREDIENTS (7)

ciprofloxacin hydrochlorideActive
Quantity: 3.5 mg in 1 mL
Code: 4BA73M5E37
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
sodium acetateInactive
Code: 4550K0SC9B
Classification: IACT
mannitolInactive
Code: 3OWL53L36A
Classification: IACT
edetate disodiumInactive
Code: 7FLD91C86K
Classification: IACT
acetic acidInactive
Code: Q40Q9N063P
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ciprofloxacin Hydrochloride - FDA Drug Approval Details